NMDA/DA Interactions
Showing 1 - 25 of 3,460
Healthy Trial in Soeul (DA-8010 5mg, Paroxetine 20mg, Mirabegron 50mg)
Not yet recruiting
- Healthy
- DA-8010 5mg
- +2 more
-
Soeul, Korea, Republic ofSeoul National University Hospital
Aug 7, 2023
Familial Alcoholism Vulnerability Trial in Hartford (Mavoglurant (AFQ056), Placebo)
Completed
- Familial Alcoholism Vulnerability
- Mavoglurant (AFQ056)
- Placebo
-
Hartford, ConnecticutHartford Hospital
Jan 7, 2022
Healthy Trial in Hartford (Memantine, Placebo)
Completed
- Healthy
- Memantine
- Placebo
-
Hartford, ConnecticutOlin Neuropsychiatry Research Center at the Institute of Living,
Feb 25, 2021
Treatment Resistant Schizophrenia Trial in Bhubaneswar (Dextromethorphan, Placebo)
Not yet recruiting
- Treatment Resistant Schizophrenia
- Dextromethorphan
- Placebo
-
Bhubaneswar, Odisha, IndiaAll India Institute of Medical Sciences (AIIMS)
Jul 15, 2023
Opioid Use, Sedative Use Trial in Lexington (Opioid Agonist, Sedatives)
Recruiting
- Opioid Use
- Sedative Use
- Opioid Agonist
- Sedatives
-
Lexington, KentuckyCenter on Drug and Alcohol Research
Nov 17, 2022
Tracheomalacia Trial in New York (Dynamic Airway CT scan (DA-CT))
Recruiting
- Tracheomalacia
- Dynamic Airway CT scan (DA-CT)
-
New York, New York
- +1 more
Sep 1, 2023
da Vinci SP Surgical System for Single-Port Gynecological
Recruiting
- Gynecological Surgeries
- da Vinci SP Surgical System
-
Shanghai, Shanghai, ChinaShanghai JiaoTong University School of Medicine affliated Ruijin
Oct 8, 2023
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Healthy Trial in Seoul (DA-5218, DA-5218-R1 + DA-5218-R2 + DA-5218-R3)
Not yet recruiting
- Healthy
- DA-5218
- DA-5218-R1 + DA-5218-R2 + DA-5218-R3
-
Seoul, Korea, Republic ofBumin Hospital
Jul 4, 2022
Cannabis, Ketamine Trial in West Haven (Active Delta-9-THC, Placebo Delta-9-THC, Active Ketamine)
Recruiting
- Cannabis
- Ketamine
- Active Delta-9-THC
- +3 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Jan 27, 2022
da Vinci SP Surgical System for Single-Port Colorectal
Recruiting
- Single-Port Colorectal Surgeries
- procedure
-
Shanghai, Shanghai, ChinaRuijin Hospital
Nov 15, 2023
Gastritis Acute, Gastritis Chronic Trial (DA-5219, Stillen® Tab, DA-5219 Placebo)
Not yet recruiting
- Gastritis Acute
- Gastritis Chronic
- DA-5219
- +3 more
- (no location specified)
Nov 21, 2023
Decision Aid Trial in Québec (DA Scaling Strategies)
Recruiting
- Decision Aid
- DA Scaling Strategies
-
Québec, CanadaVITAM - Centre de recherche en santé durable, CIUSSS de la Capit
May 12, 2023
Healthy Trial in Soeul (DA-5216, DA-5216-R)
Not yet recruiting
- Healthy
- DA-5216, DA-5216-R
- DA-5216
-
Soeul, Korea, Republic ofSeoul National University Hospital
Aug 16, 2022
Healthy Trial in Seoul (DA-5211, DA-5211-R1 + DA-5211-R2)
Completed
- Healthy
- DA-5211
- DA-5211-R1 + DA-5211-R2
-
Seoul, Korea, Republic ofBumin Hospital
Jun 2, 2022
Schizophrenia Trial in Taichung (NMDAE plus AIFA, NMDAE plus Placebo Cap)
Recruiting
- Schizophrenia
- NMDAE plus AIFA
- NMDAE plus Placebo Cap
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Jul 19, 2022
Renal Impairment, Healthy Trial in Gyeonggi-do (DA-8010)
Not yet recruiting
- Renal Impairment
- Healthy
-
Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Apr 2, 2023
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Motivation Trial in Maastricht (, haloperidol 2mg, propranolol 40mg)
Completed
- Motivation
- placebo
- +2 more
-
Maastricht, NetherlandsMaastricht University
Aug 23, 2023
Healthy Trial (DA-8010 5mg, Clarithromycin 500mg, Rifampicin 600mg)
Not yet recruiting
- Healthy
- DA-8010 5mg
- +2 more
- (no location specified)
Aug 11, 2023